Rising COVID-19 cases in India prompt concerns about deep vein thrombosis risks, with WHO tracking SARS-CoV-2 variants ...

Researchers sought to determine whether a reduced dose of apixaban would be as effective as using full-dose apixaban in preventing recurrent VTE in patients with active cancer.

The Global Mechanical Thrombectomy Devices Market was valued at $760 million in 2021 and is set to witness a healthy growth rate of 6% in the next 5 years. The growing cases of stroke, venous ...

The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) released new and ...

VTE sometimes manifests as deep vein thrombosis, when a blood clot forms in the deep veins, or pulmonary embolism, when a blood clot blocks an artery in the lung. Although the incidence of VTE in ...

although DVT often causes leg pain, swelling, warmth and erythema, while signs and symptoms of PE include chest pain, dyspnoea and haemoptysis. “VTE is a significant cause of mortality and morbidity ...

The American Medical Group Association (AMGA) recently presented North Mississippi Health Services with the group’s first ...

patients who developed DVT postdischarge were slightly older (56.5 vs 55.8 y; p = 0.0127), had a higher occurrence of prior VTE (26.2% vs 3.4%; p < 0.0001), and had undergone recent surgical ...

Pantep Angchaisuksiri, MD, ISTH president VTE sometimes manifests as deep vein thrombosis, when a blood clot forms in the deep veins, or pulmonary embolism, when a blood clot blocks an artery in ...

DVT or PE (conditional recommendation). Six weeks of anticoagulation is suggested rather than three months for select pediatric patients with provoked VTE (conditional recommendation ...

Among the 297 patients who were hospitalized with a diagnosis of postoperative venous thromboembolism, 203 (68.4 percent) had venous thrombosis alone and 94 (31.6 percent) had pulmonary embolism.

AC = anticoagulation; DVT = deep venous thrombosis; PE = pulmonary embolism; VTE = venous thromboembolism, eg, DVT and/or PE. *Primary prophylaxis not feasible owing to high bleeding risk ...